New Drug Application

The New Drug Application (NDA) is a crucial document submitted to regulatory agencies like the U.S. Food and Drug Administration (FDA) for market approval of a new drug. It's a comprehensive report detailing everything known about the drug, including its chemistry, manufacturing, animal studies, human pharmacokinetics, clinical trial results, statistics, and microbiology. The NDA also includes proposed labeling, which outlines the drug's intended uses and safety claims. This extensive documentation allows regulatory agencies to assess the drug's risk-to-benefit ratio before it can be marketed. The NDA is significantly larger and more detailed than the Investigational New Drug (IND) application, which is required to begin human studies.12